Cardiometabolic disease in human immunodeficiency virus-infected children.

Tracie L Miller, Yoran T. Grant, Daniela Neri Almeida, Tanvi Sharma, Steven E Lipshultz

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Cardiometabolic problems in children with human immunodeficiency virus (HIV) infection have recently begun to emerge as distinct clinical problems that require monitoring and often intervention. The cardiometabolic issues that face HIV-infected children include high rates of unfavorable lipid profiles, insulin resistance, cardiovascular inflammation, and vascular stiffness as well as the phenotypic features of truncal adiposity and facial/extremity wasting. Children differ from adults in that many have been exposed to both HIV and antiretroviral therapies even before birth. The future risk of adverse cardiovascular outcomes is poorly defined yet warrants close tracking because a number of risk factors are present in early childhood. Preventive care and interventions that include surveillance of nutrition and body composition, dietary counseling, exercise programs, and drug therapy should be considered standard care for all HIV-infected children.

Original languageEnglish
Pages (from-to)98-105
Number of pages8
JournalJournal of the CardioMetabolic Syndrome
Volume3
Issue number2
StatePublished - Mar 1 2008

Fingerprint

HIV
Exercise Therapy
Vascular Stiffness
Preventive Medicine
Adiposity
Virus Diseases
Body Composition
Insulin Resistance
Counseling
Extremities
Parturition
Inflammation
Lipids
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Miller, T. L., Grant, Y. T., Almeida, D. N., Sharma, T., & Lipshultz, S. E. (2008). Cardiometabolic disease in human immunodeficiency virus-infected children. Journal of the CardioMetabolic Syndrome, 3(2), 98-105.

Cardiometabolic disease in human immunodeficiency virus-infected children. / Miller, Tracie L; Grant, Yoran T.; Almeida, Daniela Neri; Sharma, Tanvi; Lipshultz, Steven E.

In: Journal of the CardioMetabolic Syndrome, Vol. 3, No. 2, 01.03.2008, p. 98-105.

Research output: Contribution to journalArticle

Miller, TL, Grant, YT, Almeida, DN, Sharma, T & Lipshultz, SE 2008, 'Cardiometabolic disease in human immunodeficiency virus-infected children.', Journal of the CardioMetabolic Syndrome, vol. 3, no. 2, pp. 98-105.
Miller TL, Grant YT, Almeida DN, Sharma T, Lipshultz SE. Cardiometabolic disease in human immunodeficiency virus-infected children. Journal of the CardioMetabolic Syndrome. 2008 Mar 1;3(2):98-105.
Miller, Tracie L ; Grant, Yoran T. ; Almeida, Daniela Neri ; Sharma, Tanvi ; Lipshultz, Steven E. / Cardiometabolic disease in human immunodeficiency virus-infected children. In: Journal of the CardioMetabolic Syndrome. 2008 ; Vol. 3, No. 2. pp. 98-105.
@article{260b7d37c8ba428ea8d2ccdac938de8a,
title = "Cardiometabolic disease in human immunodeficiency virus-infected children.",
abstract = "Cardiometabolic problems in children with human immunodeficiency virus (HIV) infection have recently begun to emerge as distinct clinical problems that require monitoring and often intervention. The cardiometabolic issues that face HIV-infected children include high rates of unfavorable lipid profiles, insulin resistance, cardiovascular inflammation, and vascular stiffness as well as the phenotypic features of truncal adiposity and facial/extremity wasting. Children differ from adults in that many have been exposed to both HIV and antiretroviral therapies even before birth. The future risk of adverse cardiovascular outcomes is poorly defined yet warrants close tracking because a number of risk factors are present in early childhood. Preventive care and interventions that include surveillance of nutrition and body composition, dietary counseling, exercise programs, and drug therapy should be considered standard care for all HIV-infected children.",
author = "Miller, {Tracie L} and Grant, {Yoran T.} and Almeida, {Daniela Neri} and Tanvi Sharma and Lipshultz, {Steven E}",
year = "2008",
month = "3",
day = "1",
language = "English",
volume = "3",
pages = "98--105",
journal = "Journal of the CardioMetabolic Syndrome",
issn = "1559-4564",
publisher = "Le Jacq Ltd.",
number = "2",

}

TY - JOUR

T1 - Cardiometabolic disease in human immunodeficiency virus-infected children.

AU - Miller, Tracie L

AU - Grant, Yoran T.

AU - Almeida, Daniela Neri

AU - Sharma, Tanvi

AU - Lipshultz, Steven E

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Cardiometabolic problems in children with human immunodeficiency virus (HIV) infection have recently begun to emerge as distinct clinical problems that require monitoring and often intervention. The cardiometabolic issues that face HIV-infected children include high rates of unfavorable lipid profiles, insulin resistance, cardiovascular inflammation, and vascular stiffness as well as the phenotypic features of truncal adiposity and facial/extremity wasting. Children differ from adults in that many have been exposed to both HIV and antiretroviral therapies even before birth. The future risk of adverse cardiovascular outcomes is poorly defined yet warrants close tracking because a number of risk factors are present in early childhood. Preventive care and interventions that include surveillance of nutrition and body composition, dietary counseling, exercise programs, and drug therapy should be considered standard care for all HIV-infected children.

AB - Cardiometabolic problems in children with human immunodeficiency virus (HIV) infection have recently begun to emerge as distinct clinical problems that require monitoring and often intervention. The cardiometabolic issues that face HIV-infected children include high rates of unfavorable lipid profiles, insulin resistance, cardiovascular inflammation, and vascular stiffness as well as the phenotypic features of truncal adiposity and facial/extremity wasting. Children differ from adults in that many have been exposed to both HIV and antiretroviral therapies even before birth. The future risk of adverse cardiovascular outcomes is poorly defined yet warrants close tracking because a number of risk factors are present in early childhood. Preventive care and interventions that include surveillance of nutrition and body composition, dietary counseling, exercise programs, and drug therapy should be considered standard care for all HIV-infected children.

UR - http://www.scopus.com/inward/record.url?scp=65849281086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65849281086&partnerID=8YFLogxK

M3 - Article

C2 - 18453810

AN - SCOPUS:65849281086

VL - 3

SP - 98

EP - 105

JO - Journal of the CardioMetabolic Syndrome

JF - Journal of the CardioMetabolic Syndrome

SN - 1559-4564

IS - 2

ER -